Ki16425

Ki16425 (Debio 0719) is a potent, reversible, and competitive antagonist of lysophosphatidic acid receptors LPA1, LPA2, and LPA3. It is widely used in both in vitro and in vivo research to investigate LPA signaling pathways in fields such as fibrosis, cancer, and neuropathic pain.

Product Specifications

CAS Number

355025-24-0

Product Name Alternative

LPA Receptor, LPA2, LPA1, LPAReceptor, LPA3, LPL, LPL Receptor, LPLReceptor, Lysophospholipid Receptor, inhibit, Ki16425, Ki-16425, Ki 16425, Inhibitor, Debio0719, Debio-0719, Debio 0719

Field of Research

Pharmacology & Drug Discovery, Stem Cell & Developmental Biology

Purity

96.15% (May vary between batches)

Solubility

10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.95 mM) ; DMSO:94 mg/mL (197.91 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:84 mg/mL (176.86 mM)